Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis

Scientific Reports

Volumn 5, Issue , 2015, Pages 8061-

  Bae, Seong Yeon ^a   Kim, Hyun Jung ^a   Lee, Kong Joo ^a   Lee, Kyunglim ^a  

^a Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; PROTEIN KINASE B; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2; TUMOR MARKER; TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1;

ALLOTRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PHENOTYPE; PIG; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR INVASION;

ANIMALS; BETA CATENIN; BIOMARKERS, TUMOR; CELL LINE; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIPROTEIN COMPLEXES; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SWINE; TOR SERINE-THREONINE KINASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84923086498     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08061     Document Type: Article

References (56)

1. Gachet, Y. et al. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell Sci. 112, 1257-1271 (1999).
2. Ma, Q. et al. The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J. Proteome Res. 9, 40-49, doi:10.1021/pr9001367 (2010).
3. Jung, J. et al . Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J. Biol. Chem. 279, 49868-49875, doi:10.1074/jbc.M400895200 (2004).
4. Kim, M. J. et al. Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na1,K1-ATPase. J. Mol. Cell Cardiol. 44, 151-159, doi:10.1016/j.yjmcc.2007.09.017 (2008).
5. Kim, M. J. et al. Over-expression of translationally controlled tumor protein in lens epithelial cells seems to be associated with cataract development. Transgenic Res. 18, 953-960, doi:10.1007/s11248-009-9283-y (2009).
6. Jung, J., Kim, H. Y., Kim,M., Sohn, K. & Lee, K. Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src. Oncogene 30, 2264-2274, doi:10.1038/onc.2010.604 (2011).
7. Rajasekaran, S. et al. Na,K-ATPase subunits as markers for epithelialmesenchymal transition in cancer and fibrosis. Mol. Cancer Ther. 9, 1515-1524, doi:10.1158/1535-7163.mct-09-0832 (2010).
8. Kalluri, R. & Weinberg, R. The basics of epithelial-mesenchymal transition. The J. Clin. Invest. 119, 1420-1428, doi:10.1172/jci39104 (2009).
9. Thiery, J. & Sleeman, J. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142, doi:10.1038/nrm1835 (2006).
10. Locascio, A. & Nieto, M. A. Cell movements during vertebrate development: integrated tissue behaviour versus individual cell migration. Curr. Opin. Genet. Dev. 11, 464-469 (2001).
11. Lee, J., Dedhar, S., Kalluri, R. & Thompson, E. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981, doi:10.1083/jcb.200601018 (2006).
12. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564, doi:10.1126/science.1203543 (2011).
13. Liang, X. EMT: new signals from the invasive front. Oral Oncol. 47, 686-687, doi:10.1016/j.oraloncology.2011.04.016 (2011).
14. Chung, S., Kim, M., Choi, W., Chung, J. & Lee, K. Expression of translationally controlled tumor protein mRNA in human colon cancer. Cancer Lett. 156, 185-190 (2000).
15. Arcuri, F. et al. Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity. Prostate 60, 130-140, doi:10.1002/pros.20054 (2004).
16. Chan, T. et al. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. Hepatology 55, 491-505, doi:10.1002/hep.24709 (2012).
17. Malgorzata, K. et al. Inverse relationship between TCTP/RhoA and p53//cyclin A/ actin expression in ovarian cancer cells. Folia Histochem. Cyto. 50, 358-367 doi:10.5603/19745 (2012).
18. Gu, X. et al. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced b-catenin/TCF-4 transcription. Neuro-oncology 16, 217-227, doi:10.1093/neuonc/not194 (2014).
19. Graidist, P. et al. Fortilin binds Ca21 and blocks Ca21-dependent apoptosis in vivo. Biochem. J. 408, 181-191, doi:10.1042/BJ20070679 (2007).
20. Acloque, H., Adams, M., Fishwick, K., Bronner-Fraser, M. & Nieto,M. Epithelialmesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438-1449, doi:10.1172/jci38019 (2009).
21. Tiwari, N., Gheldof, A., Tatari, M. & Christofori, G. EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol. 22, 194-207, doi:10.1016/j.semcancer.2012.02.013 (2012).
22. Gulhati, P. et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71, 3246-3256, doi:10.1158/0008-5472.CAN-10-4058 (2011).
23. Yilmaz, M. & Christofori, G. EMT, the cytoskeleton, and cancer cell invasion. Cancer metast. Rev. 28, 15-33, doi:10.1007/s10555-008-9169-0 (2009).
24. Chambers, A. F. & Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270 (1997).
25. Kim, M., Jung, J. & Lee, K. Roles of ERK, PI3 kinase, and PLC-gamma pathways induced by overexpression of translationally controlled tumor protein in HeLa cells. Arch. Biochem. Biophys. 485, 82-87 (2009).
26. Alessi, D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7, 261-269 (1997).
27. Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101, doi:10.1126/science.1106148 (2005).
28. Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274, doi:10.1016/j.cell.2007.06.009 (2007).
29. Müller, T., Bain, G., Wang, X. & Papkoff, J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp. Cell Res. 280, 119-133, doi:10.1006/excr.2002.5630 (2002).
30. Bazile, F. et al . Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells. Carcinogenesis 30, 555-565, doi:10.1093/carcin/bgp022 (2009).
31. Wang, W. et al. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J. Cell Biol. 173, 395-404, doi:10.1083/jcb.200510115 (2006).
32. Tsarova, K., Yarmola, E. G. & Bubb, M. R. Identification of a cofilin-like actinbinding site on translationally controlled tumor protein (TCTP). FEBS Lett. 584, 4756-4760, doi:10.1016/j.febslet.2010.10.054 (2010).
33. Ridley, A. J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16, 522-529, doi:10.1016/j.tcb.2006.08.006 (2006).
34. Cheng, I. K. et al. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J. Pathol. 228, 575-585, doi:10.1002/path.4084 (2012).
35. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
36. Sarbassov, D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycininsensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302, doi:10.1016/j.cub.2004.06.054 (2004).
37. Hay, N. & Sonenberg, N. Upstream and downstream of mTOR. Gene. Dev. 18, 1926-1945, doi:10.1101/gad.1212704 (2004).
38. Wang, X. et al. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling. J. Biol. Chem. 283, 30482-30492, doi:10.1074/jbc.M803348200 (2008).
39. Dong, X., Yang, B., Li, Y., Zhong, C. & Ding, J. Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein. J. Biol. Chem. 284, 23754-23764, doi:10.1074/jbc.M109.012823 (2009).
40. Kim, D. K. et al. Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes. Diabetologia 55, 1205-1217, doi:10.1007/s00125-012-2467-7 (2012).
41. Hsu, Y.-C., Chern, J., Cai, Y., Liu, M. & Choi, K.-W. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445, 785-788, doi:10.1038/nature05528 (2007).
42. Jacinto, E. et al.Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128, doi: 10.1038/ncb1183 (2004).
43. Cavallaro, U. & Christofori, G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4, 118-132, doi:10.1038/nrc1276 (2004).
44. Perl, A., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193, doi:10.1038/32433 (1998).
45. Conacci-Sorrell, M. et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J.Cell Biol. 163, 847-857, doi:10.1083/jcb.200308162 (2003).
46. Sanchez-Tillo, E. et al. beta-catenin/TCF4 complex induces the epithelial-tomesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc. Natl. Acad. Sci. U S A 108, 19204-19209, doi:10.1073/pnas.1108977108 (2011).
47. Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metast. Rev. 9, 289-303 (1990).
48. Vihinen, P. & Kahari, V. M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99, 157-166, doi:10.1002/ijc.10329 (2002).
49. Hadler-Olsen, E., Winberg, J. O.&Uhlin-Hansen, L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumor Biol. 34, 2041-2051, doi:10.1007/s13277-013-0842-8 (2013).
50. Lamar, J. M., Pumiglia, K. M. & DiPersio, C. M. An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion. Cancer Res. 68, 7371-7379, doi:10.1158/0008-5472.CAN-08-1080 (2008).
51. Yoon, T., Kim, M. & Lee, K. Inhibition of Na,K-ATPase-suppressive activity of translationally controlled tumor protein by sorting nexin 6. FEBS Lett. 580, 3558-3564, doi:10.1016/j.febslet.2006.05.042 (2006).
52. Kim, E. et al. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 30, 2954-2963, doi:10.1038/onc.2011.22 (2011).
53. Sheverdin, V., Bae, S. Y., Shin, D. H. & Lee, K. Expression and localization of translationally controlled tumor protein in rat urinary organs. Microsc. Res. Tech. 75, 1576-1581, doi:10.1002/jemt.22103 (2012).
54. Kasai, H.,Allen, J. T.,Mason, R.M., Kamimura, T.&Zhang, Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56, doi:10.1186/1465-9921-6-56 (2005).
55. Meng, X. et al.Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation. Cell Death Dis. 5, e1092, doi:10.1038/cddis.2014.32 (2014).
56. Kim, H. et al. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28, 117-127, doi:10.1038/onc.2008.364 (2009).